Evidence map›Paper›PMID 36408087›Full record

ArticleClinical case reports2022

Successful treatment of persistent and severe SARS-CoV-2 infection in a high-risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies.

Fernanda Braga Seganfredo, Ana Raquel Dias, Pedro R Santos, Marta Rebelo, Cristina João, Dina Mendes, Eduarda Carmo

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Fernanda Braga SeganfredoHaematology Department Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG) Lisbon Portugal.ORCID https://orcid.org/0000-0003-1495-9776
Ana Raquel DiasHaematology Department Hospital do Divino Espírito Santo de Ponta Delgada Ponta Delgada Portugal.ORCID https://orcid.org/0000-0001-6902-464X
Pedro R SantosIntensive Care Unit Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz Lisbon Portugal.
Marta RebeloIntensive Care Unit Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz Lisbon Portugal.
Cristina JoãoHaematology Department Fundação Champalimaud Lisbon Portugal.ORCID https://orcid.org/0000-0002-3978-766X
Dina MendesPharmaceutical Department Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz Lisbon Portugal.ORCID https://orcid.org/0000-0001-8708-0506
Eduarda CarmoIntensive Care Unit Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz Lisbon Portugal.
Hospital de Egas Moniz · PTChampalimaud Foundation · PTHospital do Divino Espírito Santo · PTInstituto Português de Oncologia de Coimbra Francisco Gentil · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with lymphoproliferative diseases are at an increased risk of an incomplete immune response following vaccination or SARS-CoV-2 infection and might develop persistent viral infection and severe COVID-19 disease. We present a case of successful treatment of persistent and mechanical-ventilation-requiring SARS-CoV-2 infection in a del17

Indexed as

Casirivimab and ImdevimabCOVID‐19haemato‐oncological patientsimmunity

Identifiers

PMID36408087
PMCPMC9666912
OpenAlexW4309638310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.